Home »
Academic Articles & Research Papers
Showing 6 of 6 academic articles
Xiao Lin, Jun-Jie Yang, Bei Huang, Peng-Xin Wang et al. • Experimental Gerontology
(2026)
Background: BMI cannot distinguish fat distribution and may mask the true effects of different fat depots on bone mineral density (BMD). To investigate sex- and age-specific associations between fat distribution and BMD and its mediating ro...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.exger.2026.113301
Regan Seipp, Nan Zhang, Sumi Sukumaran Nair, Hasan Khamash et al. • PLoS ONE
(2021)
BackgroundThe objective is to assess cardiovascular (CV), malignancy, infectious, graft outcomes and tacrolimus levels for the Indigenous patients compared to Whites after kidney transplant (KTx).Methods165 Indigenous and 165 White patients...
DOAJ
Open Access (DOAJ)
DOI: 10.1371/journal.pone.0244492
Okonogi Noriyuki, Hashimoto Takatuki, Ishida Masaya, Ohno Toshiki et al. • Radiation Oncology
(2012)
Abstract Background Proton-beam therapy (PBT) provides therapeutic advantages over conformal x-ray therapy in sparing organs at risk when treating esophageal cancer because of the fundamental physical dose distribution of the proton-beam. H...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/1748-717X-7-173
Davis-Ajami ML, Wu J, Downton K, Ludeman E et al. • Biologics: Targets & Therapy
(2014)
Mary Lynn Davis-Ajami,1 Jun Wu,2 Katherine Downton,3 Emilie Ludeman,3 Virginia Noxon4 1Organizational Systems and Adult Health, University of Maryland School of Nursing, Baltimore, MD, USA; 2South Carolina College of Pharmacy, University of...
DOAJ
Open Access (DOAJ)
O.O. Khaustova, A.E. Asanova, N.O. Dzeruzhynska, M.M. Matiash • Medičnì Perspektivi
(2024)
Determining the optimal antipsychotic drugs, its effective dose, duration of therapy, form, and route of administration play a key role in the treatment of schizophrenia. In addition, special attention should be paid to the effectiveness of...
DOAJ
Open Access (DOAJ)
DOI: 10.26641/2307-0404.2024.1.300499
Chunfu Wang, Songmao Liang, Jiachen Xu, Yingfan Zhai et al. • Separations
(2024)
Futibatinib is an excellent fibroblast growth factor receptor 1–4 (FGFR 1–4) inhibitor that exhibits selective anti-tumor activeness against FGFR-deregulated tumors. A new high-performance liquid chromatography-tandem mass spectrometry (HPL...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/separations11070213